Nexgel (NXGLW) Other financing activities (2024 - 2025)
Nexgel's (NXGLW) quarterly Other financing activities came in at -$92000.0 in Q4 2025, down 105.62% YoY from $1.6 million in Q4 2024, and down 105.62% on a QoQ basis from $1.6 million in Q4 2024.
Nexgel (NXGLW) Other financing activities (2024 - 2025) Analysis & Trends
Nexgel (NXGLW) has 2 years of Other financing activities data on file, last reported at -$92000.0 in Q4 2025.
- Quarterly Other financing activities fell 105.62% year-over-year to -$92000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (down 27.52% YoY) and the FY2025 annual result came in at $963000.0, down 74.47% from the prior year.
- Other financing activities declined to -$92000.0 in Q4 2025, from $1.6 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.6 million in Q4 2024 to a low of -$92000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -92,000.00 |
| Dec 31, 2025 | -92,000.00 |
| Dec 31, 2024 | 1.64 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 946,000.00 |
| Mar 31, 2024 | 946,000.00 |